Argent Trust CO Dexcom Inc Transaction History

Argent Trust CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $8,660 - $10,085	-77 Reduced 3.88%	1,907 $245,000
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $6,240 - $7,375	60 Added 3.12%	1,984 $230,000
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $163,501 - $236,017	1,924 New	1,924 $217,000
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $137,951 - $269,633	2,029 Added 211.57%	2,988 $223,000
Q1 2022 May 11, 2022	SELL	$94.08 - $130.2 $15,523 - $21,482	-165 Reduced 14.68%	959 $491,000
Q4 2021 Feb 09, 2022	SELL	$129.87 - $162.82 $7,792 - $9,769	-60 Reduced 5.07%	1,124 $604,000
Q3 2021 Nov 09, 2021	BUY	$106.71 - $143.18 $640 - $859	6 Added 0.51%	1,184 $648,000
Q2 2021 Aug 09, 2021	BUY	$80.99 - $107.93 $4,454 - $5,936	55 Added 4.9%	1,178 $503,000
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $17,316 - $23,199	222 Added 24.64%	1,123 $415,000
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $18,242 - $21,573	191 Added 26.9%	901 $372,000
Q2 2020 Aug 04, 2020	SELL	$62.68 - $105.34 $4,199 - $7,057	-67 Reduced 8.62%	710 $288,000
Q1 2020 May 11, 2020	SELL	$47.79 - $75.63 $7,120 - $11,268	-149 Reduced 16.09%	777 $209,000
Q4 2019 Feb 11, 2020	BUY	$36.62 - $57.29 $33,910 - $53,050	926 New	926 $202,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

Stay updated on Argent Trust CO with notifications on news.